DNA and dementia research podcast — how single-molecule DNA science is transforming dementia science and diagnosis.
A biophysics podcast episode explaining single molecule DNA technologies, long-read sequencing, and the molecular biology of dementia and other brain diseases.
Understand how DNA damage and dementia are linked, and how cutting-edge single-molecule methods reveal the real causes of dementia at the genomic level.
What You'll Learn:
- How single-molecule DNA techniques work and why they are revolutionizing dementia research and dementia science.
- Why ultra-long single-molecule sequencing reads (over 4 Mb) can span entire gene clusters and unlock hidden disease variants.
- What somatic mosaicism is, and how single-cell, long-read studies revealing ~1000 unique mutations per neuron change our view of how dementia works.
- How DNA damage and dementia are connected through structural variants, repeat expansions, and neuron-specific genomic changes.
- Why C9orf72 repeat expansions (>1000 GGGGCC copies) drive ~40% of familial frontotemporal dementia/ALS cases, and why only long-read or optical assays can size them accurately.
- How combining complementary biophysics tools (optical tweezers, single-molecule imaging, long-read sequencing, and more) gives a 3D view of DNA behavior in brain cells.
- What new single-molecule insights could mean for early detection, risk prediction, and future treatments for dementia and related brain diseases.
- Practical limits and promises of current single-molecule technologies, and where the next breakthroughs in DNA and dementia research are likely to come from.
About the Guest:
Professor John van Noort is a leading biophysicist whose work focuses on the physical principles that govern DNA organization and dynamics in living cells. Together with four top biophysics research teams, he recently co-authored a landmark Science review on single-molecule approaches to understanding complex diseases. His expertise bridges physics, molecular biology, and neuroscience, making him uniquely positioned to explain how DNA-level insights can transform dementia research.
